Effect of a new anti-ulcer drug, (3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride, TEI-5103) on prostaglandin (PG) levels in rat gastric mucosa.
1. Effect of TEI-5103 on the levels of various prostaglandins (PG's) in rat gastric mucosa was studied by HPLC and RIA methods. 2. When administrated in vivo, TEI-5103 significantly increased the level of prostaglandin E2 (PGE2) but only slightly increased that of prostaglandin I2 (PGI2) or thromboxane A2 (TXA2). 3. In the water-immersion stress model, the PGE2 level in control animals was increased immediately after stress and then decreased gradually to the initial level. Indomethacin (5 mg/kg, s.c.) sustained a lower PGE2 level during the experiment, as well as aggravated the lesions. 4. TEI-5103 (400 mg/kg, p.o.) increased the PGE2 level just before stress, and it resulted in the prevention of lesion formation. 5. TEI-5103 inhibited the activity of 15-OH-PG-dehydrogenase from guinea pig lungs, but did not affect the activity of phospholipase A2 from porcine pancreas.